Adenosine Receptor Agonists, Partial Agonists, and Antagonists Read more about Adenosine Receptor Agonists, Partial Agonists, and Antagonists US Patent 9,181,253Filed on 2012-05-24
Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment Read more about Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment US Patent 8,318,666Filed on 2011-05-09
Methanocarba Adenosine Derivatives, Pharmaceutical Compositions, and Method of Reducing Intraocular Pressure Read more about Methanocarba Adenosine Derivatives, Pharmaceutical Compositions, and Method of Reducing Intraocular Pressure US Patent 8,518,957Filed on 2012-06-21
Methanocarba Adenosine Derivatives And Dendrimer Conjugates Thereof Read more about Methanocarba Adenosine Derivatives And Dendrimer Conjugates Thereof European Patent10788201.1Filed on 2010-12-02
PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS Read more about PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS Japan128779/2012Filed on 2012-06-06
Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. Read more about Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. United Kingdom97905627.2Filed on 1997-01-29
Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. Read more about Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. France97905627.2Filed on 1997-01-29
Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. Read more about Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. Germany97905627.2Filed on 1997-01-29
EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE Read more about EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE MexicoMX/A/2009/003750Filed on 2009-04-06
EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE Read more about EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE Japan2009531464Filed on 2009-04-06